Nasdaq:US$38.93 (+1.39) | HKEX:HK$61.00 (+0.90) | AIM:£5.68 (+0.12)
主要股东

和黄医药共发行864,417,280股普通股。于纳斯达克上市的每股美国存托股份(ADS) 相当于五股普通股。

仅作说明:如果转换所有普通股, 则相当于172,883,456股纳斯达克交易的ADS。

就和黄医药而言,其已发行股本中约40.6%并非由公众持有,而是由和黄医药的董事及长江和记实业有限公司持有。长江和记实业有限公司为和黄医药主要股东。

和黄医药股本中之主要和重大权益的披露受 (i) 英国金融行为监管局(U.K. Financial Conduct Authority)披露指引及透明度规则(Disclosure Rules and Transparency Rules)第 5 章条文规定(已被纳入本公司的组织章程细则);以及 (ii) 美国 1934 年证券交易法的约束。

就和黄医药所知,持有和黄医药已发行股本之3% 或以上的股东及其董事(截至上次更新)的权益载于下表。

最后更新时间:2021年 9月 13日

主要股东

股东所持普通股数目(包括美国存托股份)所占已发行股本的概约百分比
CK Hutchison Holdings Limited (1)332,502,74038.47%
The Capital Group Companies, Inc. (2)77,676,0028.99%
JPMorgan Chase & Co. (3)51,312,7345.94%
CA Fern Parent (4)(5)40,847,5004.73%
Prudential plc group(6)33,325,2953.86%
Canada Pension Plan Investment Board (5)(7)26,883,2703.11%
Jean Eric Salata (8)25,993,4453.01%
General Atlantic Singapore HCM Pte. Ltd.(5)(9)25,835,0002.99%

Note:
(1) As announced on June 30, 2021, the Company was notified by CK Hutchison Holdings Limited that it indirectly owned 332,502,740 ordinary shares. Pursuant to the Hong Kong Securities and Future Ordinance, CK Hutchison Holdings Limited filed a disclosure form 2 with the Hong Kong Stock Exchange on July 19, 2021. In addition to 332,478,770 ordinary shares (held through Hutchison Healthcare Holdings Limited), the form 2 included 4,794 ADS (equal to 23,970 ordinary shares) currently held and 14,382 ADSs (equal to 71,910 ordinary shares) that will be transferred upon vesting of Long Term Incentive Plan awards.
(2) As of July 9, 2021, notified via disclosure form 2 filed with the Hong Kong Stock Exchange on July 16, 2021.
(3) As of July 8, 2021 notified via disclosure form 2 filed with the Hong Kong Stock Exchange on July 13, 2021.
(4) CA Fern Parent is wholly owned by several entities which are, by and through their control affiliates (including their respective general partners), ultimately controlled (directly or indirectly) by The Carlyle Group Inc., but The Carlyle Group Inc. has no beneficial interest in the underlying securities of the Company. As of Jun 30, 2021, notified via disclosure form TR-1 filed on AIM on July 2, 2021.
(5) Includes Shares subscribed for as a Cornerstone Investor in the Company’s Global Offering in June 2021.
(6) Held through indirect wholly-owned subsidiary M&G Investment Management Limited.  As notified on July 29, 2019, prior to the demerger of M&G plc from Prudential plc on October 21, 2019.
(7) As of June 30, 2021, notified via disclosure form TR-1 filed on AIM on July 16, 2020.
(8) Jean Eric Salata is Chief Executive and Founding Partner of Baring Private Equity Asia (“BPEA”). BPEA directly or indirectly controls several entities that hold voting rights in the Company. As of June 30, 2021, notified via disclosure form TR-1 filed on AIM on July 14, 2021.
(9) General Atlantic is entitled to further subscribe for up to 16,666,670 ordinary shares by exercising a warrant, in part or whole, at any time after July 2, 2020 and ending on January 3, 2022. As of July 6, 2020, notified via disclosure form TR-1 filed on AIM on July 6, 2020.

董事

董事所持普通股数目所持美国存托股份(ADS)数目所占已发行股本的概约百分比
贺隽 (Christian Hogg)10,938,02068,0351.30%
郑泽锋2,561,46014,4010.30%
杜志强1,800,000133,2370.29%
施熙德700,000100,0000.14%
苏慰国74,3170.04%
Dan Eldar19,00011,3900.009%
莫树锦12,3990.007%
Paul Carter35,2402,0370.005%
Karen Ferrante8,1820.005%
Graeme Jack5,3970.003%

备注:“持有”是指直接或间接持有的董事账户及该董事的“紧密联系人”(根据欧盟市场滥用条例(EU Market Abuse Regulation)第3条(第596/2014号)的定义)持有的任何法律或实益权益)。